GL1X · GenesisL1 explorer

Research workbench

3D structure of torpedo californica acetylcholinesterase complexed with N-piperidinopropyl-galanthamine

Analyse 3D structure of torpedo californica acetylcholinesterase complexed with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3I6M
Type
protein
Length
534 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Acetylcholinesterase
EC
3.1.1.7
UniProt
P04058
Ligands
G3X, NAG
Pockets
5 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAcetylcholinesterase (EC 3.1.1.7)protein53439% helix, 17% strandP04058

Ligands and binding sites

  • G3X · (4aS,6R,8aS)-3-methoxy-11-(3-piperidin-1-ylpropyl)-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13880.770.8636G3X
23230.560.7533empty
31210.440.7720empty
4740.360.7714empty
5670.340.7715empty

Modifications

Observed in the structure: 3 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 3I6M · 3D Structure of Torpedo californica acetylcholinesterase complexed with… · the same entry in another collection · chain A against A, TM-score 1.00
  • P04058 · AlphaFold monomer V2.0 prediction for acetylcholinesterase (P04058) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.